Zymtronix

company

About

Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.99K
Industries
Biotechnology,Genetics,Life Science,Product Research
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis.

Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.26M
Zymtronix has raised a total of $1.26M in funding over 2 rounds. Their latest funding was raised on Mar 2, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 2, 2015 Grant $1.08M 1 National Science Foundation Detail
Nov 13, 2013 Grant $179.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Zymtronix is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant